CTVA Corteva

Q2 2025 10-Q

Filed: Aug 7, 2025Period ending Jun 30, 2025

Agriculture

Agricultural Production-CropsSEC EDGAR

Corteva (CTVA) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Aug 7, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

AI Filing Analysis
Q2 2025 10-Q

Risk Factors

• New regulatory risk from EPA, USDA, FDA, and HHS funding and staff cuts delaying product approvals
• Most materially updated risk: regulatory delays enhanced by government agency resource constraints, impacting approval timelines

+3 more insights

Quarterly Financial Summary
XBRL

Revenue

$6.5B

▲ +5.6% YoY▲ +46.2% QoQ

Net Income

$1.3B

▲ +24.8% YoY▲ +101.5% QoQ

Net Margin

20.4%

▲ +312bp YoY▲ +559bp QoQ

EPS (Diluted)

$1.92

▲ +28.0% YoY▲ +102.1% QoQ

Operating Cash Flow

$947M

▲ +110.0% YoY▲ +144.9% QoQ

Source: XBRL data from Corteva Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other Corteva Quarterly Reports

Q3 2025 10-Q

Get deeper insights on Corteva

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.